ID   SK-OV-3/CMV-Luc
AC   CVCL_4Y19
DR   cancercelllines; CVCL_4Y19
DR   JCRB; JCRB1594
DR   JCRB; NIHS0736
DR   Wikidata; Q54954502
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter.
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Discontinued: JCRB; NIHS0736; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 13,14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 16
//